136 Results

People

  1. Abou-Alfa
    Abou-Alfa
  2. Gomez
    Gomez
  3. Simone
    Simone
  4. Shaverdian
    Shaverdian
  5. Chaft
    Chaft
  6. Hellmann
    Hellmann
  7. Rimner
    Rimner
  8. Gelblum
    Gelblum
  9. Postow
    Postow
  10. Rudin
    Rudin

Groups

  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (90)
  3. Thoracic Oncology (33)
  4. Gastrointestinal Oncology Service (31)
  5. Graduate Medical Education (25)
  6. Radiation Oncology, Department of (24)
  7. Weinberg Fellows (24)
  8. GME, Medicine (20)
  9. Department of Pathology and Laboratory Medicine (19)
  10. Sloan Kettering Institute Postdocs (18)
  1. "durvalumab"
Formats
  1. Journal Article (73)
  2. Review (47)
  3. Editorial (7)
  4. Guidelines (4)
  5. Correspondence (2)
  6. Research Letter (2)
  7. Meeting Abstract (1)
Groups
  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (90)
  3. Thoracic Oncology (33)
  4. Gastrointestinal Oncology Service (31)
  5. Graduate Medical Education (25)
  6. Radiation Oncology, Department of (24)

More Groups

People
  1. Ghassan Abou-Alfa (15)
  2. Daniel Gomez (12)
  3. Charles Simone (11)
  4. Jamie Chaft (11)
  5. Narek Shaverdian (10)
  6. Andreas Rimner (9)

More People

Years
  1. 2025 (10)
  2. 2024 (28)
  3. 2023 (27)
  4. 2022 (15)
  5. 2021 (12)
  6. 2020 (23)

More Years

Publications
  1. Journal of Thoracic Oncology (12)
  2. Annals of Oncology (7)
  3. Clinical Cancer Research (5)
  4. Journal for ImmunoTherapy of Cancer (5)
  5. Cancer Discovery (4)
  6. Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (30)
  2. Elsevier Science, Inc. (10)
  3. Oxford University Press (10)
  4. American Association for Cancer Research (9)
  5. Nature Publishing Group (9)
  6. Biomed Central Ltd (7)

More Publishers

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Journal Article

    Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Skoulidis, F.; Yeap, B. Y.; Naidoo, J.; Khosrowjerdi, S.; Mooradian, M.; Lydon, C.; Illei, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Overview of established and emerging immunohistochemical biomarkers and their role in correlative studies in MRI
    Review

    Alvi, E.; Gupta, R.; Borok, R. Z.; Escobar-Hoyos, L.; Shroyer, K. R.
    Journal of Magnetic Resonance Imaging (2020)

    Fulltext@MSK | Save
  • Immune therapy for liver cancers
    Review

    Hilmi, M.; Vienot, A.; Rousseau, B.; Neuzillet, C.
    Cancers (2020)

    Fulltext@MSK | Save
  • EURACAN/IASLC Proposals for updating the histologic classification of pleural mesothelioma: Towards a more multidisciplinary approach
    Guidelines

    Nicholson, A. G.; Sauter, J. L.; Nowak, A. K.; Kindler, H. L.; Gill, R. R.; Remy-Jardin, M.; Armato, S. G. 3rd; Fernandez-Cuesta, L.; Bueno, R.; Alcala, N.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Prognostic significance of liver metastasis in durvalumab-treated lung cancer patients
    Journal Article

    Sridhar, S.; Paz-Ares, L.; Liu, H.; Shen, K.; Morehouse, C.; Rizvi, N.; Segal, N. H.; Jin, X.; Zheng, Y.; Narwal, R.; more...
    Clinical Lung Cancer (2019)

    Fulltext@MSK | Save
  • When should we irradiate the primary in metastatic lung cancer?
    Review

    Shiarli, A. M.; McDonald, F.; Gomez, D. R.
    Clinical Oncology (2019)

    Fulltext@MSK | Save
  • New lung cancer treatments (immunotherapy and targeted therapies) and their associations with depression and other psychological side effects as compared to chemotherapy
    Journal Article

    McFarland, D. C.
    General Hospital Psychiatry (2019)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors for hepatocellular carcinoma
    Review

    El Dika, I.; Khalil, D. N.; Abou-Alfa, G. K.
    Cancer (2019)

    Fulltext@MSK | Save
  • Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Editorial

    Broderick, S. R.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2019)

    Fulltext@MSK | Save